APOE and Alzheimer disease: APOE ε4 genotype is a potential confounder of the association between the gut microbiome and AD, as it is distributed differently in the AD patients than in the controls (AD, 72% carriers; control, 20% carriers; p-value <0.001) in the study sample, and has been found to influence the gut microbiome [16].